You have 9 free searches left this month | for more free features.

CLADRIBINE

Showing 26 - 50 of 172

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Sclerosis Trial in Latham (Cladribine Tablets)

Recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Latham, New York
    Multiple Sclerosis Center of Northeastern New York, P.C.
Jan 12, 2022

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Completed
  • Multiple Sclerosis
  • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
  • Prague, Czechia
    IMPULS Endowment Fund
Mar 7, 2023

Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

Recruiting
  • Acute Myeloid Leukemia
  • CAV Regimen
  • MEC Regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Dec 22, 2022

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Cladribine
  • +5 more
  • Melbourne, Victoria, Australia
    Monash University
Aug 28, 2022

Advanced Multiple Sclerosis, Progressive Multiple Sclerosis Trial in United Kingdom (Cladribine (MAVENCLAD®), Placebo)

Recruiting
  • Advanced Multiple Sclerosis
  • Progressive Multiple Sclerosis
  • Cladribine (MAVENCLAD®)
  • Placebo
  • Belfast, United Kingdom
  • +18 more
Jun 9, 2022

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

Seasonal Influenza Vaccination in Multiple Sclerosis Patients

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Vaccine Response Impaired
  • Most recent vaccine to seasonal influenza
  • Duesseldorf, Northrhine-Westphalia, Germany
    Medical Faculty, Heinrich-Heine-University
Aug 19, 2021

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Cladribine
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 18, 2022

Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)

Recruiting
  • Secondary Acute Myeloid Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 25, 2021

Acute Myeloid Leukemia MDS Trial in Gliwice (Cladribine)

Not yet recruiting
  • Acute Myeloid Leukemia Myelodysplastic Syndromes
  • Cladribine
  • Gliwice, Poland
    Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytu
May 3, 2021

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Cladribine
  • +5 more
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Multiple Sclerosis Trial in Rouen (biological collection)

Unknown status
  • Multiple Sclerosis
  • biological collection
  • Rouen, France
    Rouen University Hospital
Mar 25, 2021

Langerhans Cell Histiocytosis of Lung Trial in Paris (Cladribine)

Unknown status
  • Langerhans Cell Histiocytosis of Lung
  • Cladribine
  • Paris, France
    Saint Louis hospital
Feb 17, 2021

Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

Leukemia Trial in Shanghai (CLAM+PBSC)

Suspended
  • Leukemia
  • Shanghai, China
    Rui Jin Hospital, Department of Hematology
Nov 23, 2021

Peripheral T-cell Lymphoma Trial in Shanghai (BEAC, Cladribine combined with BEAC)

Recruiting
  • Peripheral T-cell Lymphoma
  • BEAC
  • Cladribine combined with BEAC
  • Shanghai, Shanghai, China
    Ruijin Hospital
May 9, 2021

Refractory Hematologic Cancer, Allogeneic Stem Cell Transplantation Trial in Shanghai (CLAGE-FluBu)

Active, not recruiting
  • Refractory Hematologic Cancer
  • Allogeneic Stem Cell Transplantation
  • Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
Nov 23, 2021

Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
Apr 24, 2022

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

Completed
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Cladribine
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

Acute Leukemia, in Relapse, Acute Leukemia Refractory Trial in Suzhou (CVA regimen bridging to HSCT)

Recruiting
  • Acute Leukemia, in Relapse
  • Acute Leukemia Refractory
  • CVA regimen bridging to HSCT
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Jan 4, 2022

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University of Frankfurt, Medical Dept. II
Aug 17, 2022

Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed Trial in Guangzhou (Cladribine Injection, Aclarubicin, G-CSF)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Cladribine Injection
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

Active, not recruiting
  • Multiple Sclerosis
  • Cladribine
  • Alexandroupolis, Greece
  • +52 more
Sep 28, 2022

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Trial (Cladribine)

Not yet recruiting
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Cladribine
  • (no location specified)
Dec 17, 2020

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Cladribine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021